<!doctype html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Implantation</title>
<link rel="stylesheet" href="../../css/style.css">
<link rel="stylesheet" href="../../css/anatomy-modern.css">
</head>
<body>
<div class="container">
  <main id="content">
<h1><a id="_Toc392744135"></a><a id="_Toc469169046"></a><a id="_Toc218437398"></a>Implantation</h1><h2>Definition </h2><p>Process of sequential apposition, adhesion, and invasion of blastocyst into the uterine endometrium via trophoblast is referred as implantation.</p><div class="note-box"><p>Sequence: apposition → adhesion → invasion</p></div><h2>Site and time of implantation </h2><p>Common site of implantation is posterior wall of uterine fundus.</p><p>Time: day 6-10 post-fertilization</p><p>Fundus posterior preferred, but anterior equally viable in IVF</p><div class="clinical-box"><p>The uterus at the time of implantation will be in the secretory phase</p></div><div class="warning-box"><p><strong> </strong>hCG maintains corpus luteum and menstrual cycle ceases on successful implantation.</p></div><h2>Uterine endometrium </h2><p>The endometrium, now known as the decidua in pregnancy, thickens to form a suitable nidus for the conceptus</p><h2>Decidua </h2><ul><li>Progesterone-induced stromal hypertrophy or edema of uterine endometrium.</li><li>Forms nidus with spiral artery remodeling</li><li>Types <ul><li>Capsular (at site of implantation)</li><li>Basal (under chorion)</li><li>Parietalis (rest of the uterine endometrium)</li></ul></li></ul><h2>Confirmation of implantation </h2><p>hCG Monitoring: Syncytiotrophoblast secreted hCG rise (doubling q48h) confirms implantation; subnormal in vanishing twin or molar (cytotrophoblast overgrowth)</p><div class="video-container">
  <iframe width="560" height="315" src="https://www.youtube.com/embed/fa_2tJPm20E" 
    title="YouTube video player" frameborder="0" 
    allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" 
    referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div><h2>Trophoblast lineage </h2><ol><li>Syncytiotrophoblast <ol><li>a multinucleated mass of cytoplasm</li><li>immunologically inert, via FasL </li><li>Invasive – erodes endometrium</li><li>Produces hCG (human Chorionic Gonadotropin)</li></ol></li><li>Cytotrophoblast <ol><li>Inner cuboidal cells </li><li>Represent a germinative population of Trophoblast cells </li><li>Renews syncytiotrophoblasts</li></ol></li></ol><h2>Molecular Regulators</h2><ul><li>LIF/HOXA10 for receptivity</li><li>MMPs/integrins for invasion</li><li>hCG sustains luteal phase</li></ul><h2>Ectopic sites of implantation</h2><p>The fertilized oocyte may get implanted anywhere along the path of its journey to the uterus. Implantation outside the uterine cavity is called ectopic pregnancy. </p><p>These abnormal sites are:</p><ol><li>Fallopian tube (tubal pregnancy) – most common site of ectopic gestation (~95%)</li><li>On the ovary (ovarian pregnancy, ~3%)</li><li>In the peritoneal cavity and other orgrans (abdominal pregnancy, &lt;1%)</li><li>Cervix of uterus (cervical pregnancy) </li></ol><div class="video-container">
  <iframe width="560" height="315" src="https://www.youtube.com/embed/PAVo16b_6j4" 
    title="YouTube video player" frameborder="0" 
    allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" 
    referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div><h2>Window of Implantation (WOI)</h2><ul><li>The WOI is the optimal 4-5 day period (~days 20-24 of a 28-day menstrual cycle) when the endometrium is receptive to blastocyst implantation</li><li>It is driven by progesterone-induced decidualization and expression of adhesion molecules (e.g., integrins, LIF). </li></ul><div class="clinical-box"><p>Outside this window, the endometrium is either proliferative (pre-ovulatory, non-receptive) or refractory (post-WOI, leading to menses), explaining ~20-30% of implantation failures in IVF</p></div><h2>Clinical relevance </h2><ul><li>Ectopic pregnancy management <ul><li>Tubal ectopics (95%) risk rupture (day 6-8 invasion mimics)</li><li>β-hCG + USG detects early</li></ul></li><li>Placental Abnormalities	<ul><li>Excessive syncytiotrophoblast invasion → accreta spectrum </li><li>C-section history + USG Doppler screens, with hysterectomy prevention via interstitial laser</li></ul></li><li>Endometriosis Impact<ul><li>Impaired adhesion causes 40% infertility</li><li>pre-IVF ablation + progesterone enhances window of implantation</li></ul></li></ul><h1>Endometrial Receptivity Array (ERA)</h1><h2>Definition and Purpose</h2><p>ERA is a molecular diagnostic test used in IVF to assess endometrial receptivity by analyzing the expression of 238-248 genes from an endometrial biopsy, identifying the personalized window of implantation (WOI) for optimal embryo transfer timing</p><h2>Procedure</h2><p>Performed via a simple office biopsy (similar to a Pap smear) on cycle day ~21 (or adjusted), with RNA extracted and profiled; results take 4-6 weeks, guiding a subsequent frozen embryo transfer cycle.</p><h2>Indications</h2><p>Primarily for women with recurrent implantation failure (RIF) or unexplained infertility, as ~25% have a displaced WOI (e.g., 12-24 hours earlier/later than standard), potentially improving success rates by 20-30% in select cases</p>
  </main>
</div>

<script src="../../js/interactive-features.js"></script>
</body>
</html>